ResMed

FunderResearch funding and supported work

ResMed is a funder indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,557 works.

1,557

Works

IDs:OpenAlex

What are the most-cited papers on ResMed?

ScholarIQmost cited works

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

Bertram Pitt, Lars Køber, Piotr Ponikowski, Mihai Gheorghiade, Gerasimos Filippatos, Henry Krum, Christina Nowack, Peter Kolkhof, So Young Kim, Faı̈ez Zannad

European Heart Journal. 2013582 CitationsOPEN ACCESS

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

Gerasimos Filippatos, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faı̈ez Zannad, So Young Kim, Christina Nowack, Giovanni Palombo, Peter Kolkhof, Nina Kimmeskamp‐Kirschbaum, Alexander Pieper, Bertram Pitt

European Heart Journal. 2016438 CitationsOPEN ACCESS

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate

Logan Schneider, Anne Marie Morse, Michael Strunc, Joyce Lee‐Iannotti, Richard Bogan

Nature and Science of Sleep. 202313 CitationsOPEN ACCESS